Stocktoria
ARTELO BIOSCIENCES, INC. ARTL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-10-13
ARTELO BIOSCIENCES, INC. statistics & valuation
Market cap$3.9M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -459.8% | -209.2% | -71.2% | -49.4% | -33.3% |
| Return on equity | 1012.5% | -343.9% | -79.0% | -52.0% | -34.6% |
| Current ratio | 0.17 | 1.44 | 8.51 | 18.36 | 23.96 |
Source: SEC EDGAR filings · CIK 0001621221 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.